Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesRecent advances in prenatal genetic screening and testingEvaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases.A de novo duplication of chromosome 9q34.13-qter in a fetus with Tetralogy of Fallot Syndrome.Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y.The benefits and limitations of cell-free DNA screening for 22q11.2 deletion syndrome.Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.False negative fetal cell free DNA screening for microdeletion syndromes in the presence of an unbalanced translocation involving monosomy 4p.Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions.Pediatric healthcare costs for patients with 22q11.2 deletion syndrome.Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test.Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results.Isolation and whole genome sequencing of fetal cells from maternal blood towards the ultimate non-invasive prenatal testing.Confined placental mosaicism for 22q11.2 deletion as the etiology for discordant positive NIPT results.Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations.Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing.Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA.Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies.Screening for fetal chromosomal and subchromosomal disorders.Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples.Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon.Next generation sequencing and the next generation: how genomics is revolutionizing reproduction
P2860
Q26764809-8D0ABFE9-6B33-4B8C-A283-8BFDD71F253CQ28071888-DDB08E76-FD0B-4024-9B95-900EEA8CB971Q33809800-93BAC2F9-0A43-4100-BAFB-5F2055566413Q37340281-B9F3C3F6-71BE-4602-B94F-062201D6E2F9Q37558281-443D7512-3024-445B-BB5F-0D07FDD010EBQ37637591-FF3E4630-5BA3-4609-BA5B-B82A14DBE11BQ38837429-2CDA4451-4FCF-40F3-B9AF-C393B3D943A7Q38860845-D13A0267-5FE7-42FC-B4AC-21E0CD7D194EQ38872392-A1FDA984-730E-42D9-988B-D4DD032FA380Q39004076-600F7CEF-5268-4012-94F6-6831F79B1396Q39387768-3C6AD1DA-0746-453B-A836-8CE653FE4096Q45965934-6DC9A134-F24B-41E3-BAC8-A927195FB56FQ46058669-E6BFF1C0-F423-4CA9-A9A5-CE32AB1AD1DCQ46081566-6274D5EB-F7C2-4937-A2BF-78B302BA73CEQ46266038-778D61E5-9386-4D41-A47F-7C25F145D186Q46480890-B56D570E-0248-4C4E-A37B-910AF534A51EQ47149091-9095E1C6-5C2B-405C-BD9A-86BCFE8E8DA4Q47351507-A88E4512-C184-42BF-A1A6-54717EFF8A19Q47586484-6C068CE7-44F2-41F7-A74A-06C809557151Q48235938-84907D43-0E88-4553-A0E8-4893D53E8181Q48280857-D176C9CF-286A-4865-80F7-221C88C78926Q48282895-36EDEE3F-827F-4957-85E5-38AE94F22840Q48285694-5A925182-AFA9-4EB6-BF07-C9C3F9AB7468Q48374194-FA6E38B3-5F01-49CB-B036-3337FEA9D499Q50058086-18012600-8243-4A71-A679-6E8AF53293E4Q52688329-4248D49A-7990-44FB-B60F-3F89FAA8C51DQ53091843-5B83BFC3-945F-425D-B4F4-8E85BF62B845Q57839568-BEC6DD6A-B4A6-4D43-B40E-A3C35060EB04
P2860
Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@en
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@nl
type
label
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@en
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@nl
prefLabel
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@en
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@nl
P2093
P2860
P356
P1433
P1476
Clinical outcome of subchromos ...... noninvasive prenatal testing.
@en
P2093
D H Farkas
J Helgeson
J S Saldivar
N Dharajiya
R M McCullough
T J Monroe
P2860
P304
P356
10.1002/PD.4640
P577
2015-06-18T00:00:00Z